Back to Trades
Total Value
$22.7K
Net $22.7K sold
Filing Date
Apr 10, 2026
2 transactions
Sales
$22.7K
2 transactions
Trade Summary
On Apr 8, 2026 through Apr 9, 2026, Menu Philippe, Chief Medical Officer, sold $22.7K of SOPHiA GENETICS SA (SOPH) across 2 transactions. The filing covers Ordinary Shares and reflects net selling of $22.7K. Reported prices ranged from $4.74 to $4.84. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- SOPHiA GENETICS SA
- Ticker Symbol
- SOPH
- CIK
- 0001840706
Insider Information
- Name
- Menu Philippe
- Role
- Chief Medical Officer
Filing Details
- Filing Date
- Apr 10, 2026
- Transaction Date
- Apr 8, 2026
- Accession Number
- 0001840706-26-000139
- Form Type
- 4
- Net Trading Amount
- -$22.7K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 8, 2026 | Ordinary Shares | 2,800 | $4.84 | Sale | $13.5K |
| Apr 9, 2026 | Ordinary Shares | 1,931 | $4.74 | Sale | $9.2K |
Want live alerts when Menu Philippe trades again?
Download Insider Trades to track SOPH, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- (F2)The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F3)The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.655 to $4.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.